2014, Number 1
<< Back Next >>
Evid Med Invest Salud 2014; 7 (1)
Effect of blood glucose control in septic patients in the Intensive Care Unit
Aguilar-Gutiérrez Z, Revilla RE, Olvera SV, Chávez MA, Ramírez CJB, Ruiz OMR
Language: Spanish
References: 18
Page: 19-23
PDF size: 274.53 Kb.
ABSTRACT
Background: The metabolic response to trauma is comprised of various mechanisms of counter looking restore homeostasis immediately; one of which is the action of hormones to keep blood sugar under stress by conditioning hyperglycemia which in turn has been associated with higher rates of infection and mortality in critically ill septic patients.
Objective: To determine the effect of strict glycemic control on the development and survival of critically ill septic patients.
Material and methods: Retrospective, observational and analytical study.
Results: We included 23 patients with complete clinical records: 12 men (52%) and 11 women (48%), average age in both genders: 40. They were grouped as patients without strict control of blood glucose (CNE) (blood glucose equal to or greater than 121 mg%) strict control of blood glucose (CE) (average blood glucose between 90-120 mg%) and control. The EC group: 7 (30%) males and 6 (26%) women
versus CNE: 5 (22%) males and 6 (26%) women (OR = 1.17; p = 0.85), admission APACHE score: 21 ± 6 CE
versus 25 ± 5 CNE; days ICU long stay: 14 ± 9 CE
versus 13 ± 8 CNE; central average blood glucose 110 ± 7 mg%
versus EC 137 ± 9 mg% CNE. Risk of died 2 fold in CNE (p = 0.43).
Conclusion: Strict blood glucose control in critically ill septic patients improves their development and survival.
REFERENCES
Brøchner AC, Toft P. Pathophysiology of the systemic inflammatory response after major accidental trauma. Scand J Trauma Resusc Emerg Med 2009; 17: 43.
Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000; 85 (1): 109-117.
Mashkoor A, Choudhry K. Bland I, Irshad H. Trauma and immune response, effect of gender differences. Injury. 2007; 38 (12): 1382-1391.
Nicole E, Tiaakie V, Luke P. A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients. Crit Care. 2010: 14R: 150-159.
Falciglia M, Freyberg R, Amenoff P, D’alessio D. Hyperglycemia related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009; 37 (12): 3001-3009.
Naeem A, O’Brien J, Dungan K, Phillips G, Marsh C, Lemeshow S et al. Glucosa variability and mortality in patients with sepsis. Crit Care Med. 2008; 36: 2316-2321.
Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004; 79: 992-1000.
Falciglia M, Freyberg R, Amenoff P, D’alessio D. Hyperglycemia related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009; 37 (12): 3001-3009.
Goldstein DS. Catecholamines and stress. Endocrine Regulations. 2003; 37: 69-80.
Gómez-González B, Escobar A. Neuroanatomía del estrés. Rev Mex Neuroci. 2002; 3: 273-282.
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M. Intensive insulin therapy in critically ill patients. N Engl J. 2001; 345: 1359-1367.
Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354: 449-61.
Cunneen J, Cartwright M. The puzzle of sepsis. AACN Clinical Issues. 2004; 15: 18-44.
Carlson GL. Insulin resistance in sepsis. Br J Surg. 2003; 90: 259-260.
Martin C, Boisson C, Haccoun M, Thomachot L, Mege JL. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma. Crit Care Med. 1997; 25: 1813-1819.
Dellinger RP. Tumor necrosis factor in septic shock and multiple system trauma. Crit Care Med. 1997: 25: 1771-1773.
Jeschke MG, Klein D, Bolder U, Einspanier R. Insulin attenuates the systemic inflammatory response in endotoxine rats. Endocrinology. 2004; 145: 4084-4093.
Mesotten D, Van den Berghe G. Clinical potential of insulin therapy in critically ill patients. Drugs. 2003; 63: 625-636.